Protagonist Therapeutics Inc
PTGX
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.06B
Close$
$-4.03
103.7% downside
Current Fair Value
103.7% downsideOvervalued by 103.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $7.06 Billion |
|---|---|
| Enterprise Value | $6.88 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.05 |
| Beta | 1.83 |
| Outstanding Shares | 65,087,847 |
Return
| Return on Equity | -17.50% |
|---|---|
| Return on Assets | -16.45% |
| Return on Invested Capital | -20.55% |
Valuation & Multiples
| P/E Ratio | -62.29 |
|---|---|
| PEG | 47.03 |
| Price to Sales | - |
| Price to Book Ratio | 10.98 |
| Enterprise Value to Revenue | 386.89 |
| Enterprise Value to EBIT | -50.52 |
| Enterprise Value to Net Income | -60 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 6, 2026
EPS Estimate
$-0.65
Average shareholder expectationRevenue Estimate
$12.20 M
Average shareholder expectationNext Earnings Call
Expected Date
July 30, 2026
EPS Estimate
$2.06
Average shareholder expectationRevenue Estimate
$200.53 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.2335▲ 17.53% |
|---|---|
| Total Calls | 289,900▼ 67.75% |
| Total Puts | 67,700▲ 29.45% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 123.86%▲ 12.96% |
|---|---|
| Total Invested | $8.30B▲ 34.33% |
| Investors Holding | 3300% |
ESG Score
No data